Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 1/20 | 0.52 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.46 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.46 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25855289 | 0.98 | LPAR3 (0.50) | TYMSLPAR3LPAR2BBOX1CYP3A4 | |
| SCHEMBL28202074 | 0.98 | LPAR3 (0.50) | TYMSLPAR3LPAR2BBOX1CYP3A4 | |
| SCHEMBL22492270 | 0.98 | LPAR3 (0.50) | TYMSLPAR3LPAR2BBOX1CYP3A4 | |
| SCHEMBL28333340 | 0.98 | LPAR3 (0.50) | TYMSLPAR3LPAR2BBOX1CYP3A4 | |
| SCHEMBL28333338 | 0.98 | LPAR3 (0.50) | TYMSLPAR3LPAR2BBOX1CYP3A4 | |
| SCHEMBL26361982 | 0.92 | — | — | |
| SCHEMBL26136017 | 0.81 | — | — | |
| SCHEMBL20235 | 0.78 | TYMS (0.85) | TYMSLPAR3LPAR2BBOX1CYP3A4 | |
| SCHEMBL17107642 | 0.75 | TYMS (0.52) | TYMSLPAR3LPAR2BBOX1CYP3A4 | |
| SCHEMBL15537598 | 0.75 | TYMS (0.52) | TYMSLPAR3LPAR2BBOX1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110669458-B | Resin composition | 苏州星烁纳米科技有限公司 | 2021-06-29 | — | — | CN | disclosed |
| CN-110669458-A | Resin composition | 苏州星烁纳米科技有限公司 | 2020-01-10 | — | — | CN | disclosed |
| CN-107760232-B | resin composition, light conversion element, and light source module | 苏州星烁纳米科技有限公司 | 2019-12-17 | — | — | CN | disclosed |
| US-10023866-B2 | Compositions and methods for inhibition of nucleic acids function | Life Technologies Corporation (US) | 2018-07-17 | — | — | US | disclosed |
| US-20180057814-A1 | COMPOSITIONS AND METHODS FOR INHIBITION OF NUCLEIC ACIDS FUNCTION | Life Technologies Corporation | 2018-03-01 | — | — | US | disclosed |
| US-9783804-B2 | Compositions and methods for inhibition of nucleic acids function | Life Technologies Corporation (US) | 2017-10-10 | — | — | US | disclosed |
| US-20170009232-A1 | COMPOSITIONS AND METHODS FOR INHIBITION OF NUCLEIC ACIDS FUNCTION | Life Technologies Corporation | 2017-01-12 | — | — | US | disclosed |
| US-9410153-B2 | Compositions and methods for inhibition of nucleic acids function | Life Technologies Corporation (US) | 2016-08-09 | — | — | US | disclosed |
| EP-2558578-B1 | COMPOSITIONS AND METHODS FOR INHIBITION OF NUCLEIC ACIDS FUNCTION | LIFE TECHNOLOGIES CORP (US) | 2015-10-28 | — | — | EP | disclosed |
| US-9145556-B2 | Compositions and methods for inhibition of nucleic acids function | Life Technologies Corporation (US) | 2015-09-29 | — | — | US | disclosed |
| US-20150166992-A1 | COMPOSITIONS AND METHODS FOR INHIBITION OF NUCLEIC ACIDS FUNCTION | Life Technologies Corporation (US) | 2015-06-18 | — | — | US | disclosed |
| EP-2558578-A1 | COMPOSITIONS AND METHODS FOR INHIBITION OF NUCLEIC ACIDS FUNCTION | Life Technologies Corporation (US) | 2013-02-20 | — | — | EP | disclosed |
| WO-2011130371-A1 | COMPOSITIONS AND METHODS FOR INHIBITION OF NUCLEIC ACIDS FUNCTION | Life Technologies Corporation (US) | 2011-10-20 | — | — | WO | disclosed |
| US-20110251261-A1 | COMPOSITIONS AND METHODS FOR INHIBITION OF NUCLEIC ACIDS FUNCTION | Life Technologies Corporation (US) | 2011-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10023866-B2 | Compositions and methods for inhibition of nucleic acids function | RNGTT, NSUN3, NSUN2 | TYMS 823/4885LPAR3 1002/4885LPAR2 1486/4885 |
| US-20170009232-A1 | COMPOSITIONS AND METHODS FOR INHIBITION OF NUCLEIC ACIDS FUNCTION | RNGTT, NSUN3, NSUN2 | TYMS 823/4885LPAR3 1002/4885LPAR2 1486/4885 |
| US-20110251261-A1 | COMPOSITIONS AND METHODS FOR INHIBITION OF NUCLEIC ACIDS FUNCTION | RNGTT, NSUN3, NSUN2 | TYMS 823/4885LPAR3 1002/4885LPAR2 1486/4885 |
| US-20180057814-A1 | COMPOSITIONS AND METHODS FOR INHIBITION OF NUCLEIC ACIDS FUNCTION | RNGTT, NSUN3, NSUN2 | TYMS 823/4885LPAR3 1002/4885LPAR2 1486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.